Ultima-Stan 50 mg 50 Tablets Ultima Pharma USA
$109.00
Product Short Description
Ultima-Stan 50 mg 50 Tablets Ultima Pharma USA delivers stanozolol (C21H32N2O), the pyrazole-fused DHT anabolic steroid exhibiting extreme anabolic potency (~320:30 ratio), at premium oral 50 mg strength matching institutional performance specifications. Domestic production serves DEA Schedule III compliant channels exclusively.
Product Overview
Ultima Pharma USA’s Stan 50 mg presents stanozolol, featuring C2-C3 pyrazole substitution preventing aromatization characteristic of 17α-methylated DHT derivatives (~8-hour half-life), in USP-equivalent scored tablets for institutional catalogs. The 50-tablet tamper-evident configuration supports CIII-compliant inventory management across encrypted specialist platforms requiring batch traceability essential for DEA-regulated workflows.
U.S. domestic manufacturing eliminates customs exposure distinguishing legitimate Schedule III supply from underground tablet presses prevalent in non-verified markets. High-dosage format serves advanced resellers managing controlled substance inventories rather than discontinued prescription Winstrol (2 mg).
Ultima-Stan targets verified CIII ecosystems emphasizing commercial positioning without protocols or claims.
Brand & Manufacturer Information
Ultima Pharma USA produces Schedule III anabolics through domestic facilities serving institutional performance distribution requiring controlled substance compliance. Stan 50 mg maintains catalog continuity alongside Ultima Superdrol/Turinabol authenticating legitimate institutional supply versus powder-converted alternatives.
Active Compound Information
Contains stanozolol (17α-methyl-2’H-5α-androst-2-enopyrazol-17β-ol), heterocyclic DHT derivative enabling high anabolic:androgenic dissociation with no estrogen conversion and moderate hepatotoxicity profile characteristic of 17α-methylated oral steroids. DEA Schedule III (21 CFR 1308.13) reflects performance dosage escalation potential.
50 mg strength represents institutional-grade escalation from discontinued prescription formats. WADA S1a prohibited globally.
Product Specifications
| Specification | Details |
|---|---|
| Product Name | Ultima-Stan 50 mg 50 Tablets Ultima Pharma USA |
| Active Compound | Stanozolol (C21H32N2O) |
| Strength | 50 mg per scored tablet |
| Quantity | 50 tablets per bottle |
| Form | Oral scored tablets |
| Category | DEA Schedule III controlled substance |
| Packaging | Tamper-evident HDPE bottle |
Quality Control & Testing Standards
50 mg stanozolol mandates USP potency assay (90-110% HPLC), dissolution profiling, and uniformity verification confirming pharmaceutical-grade content. Ultima batch documentation verifies C21H32N2O identity distinguishing legitimate production.
50-tablet institutional bottling prevents diversion matching DEA protocols.
Legal & Regulatory Disclaimer
Stanozolol constitutes DEA Schedule III under 21 USC §812; non-medical handling violates Controlled Substances Act (5 years/$250,000 penalties). Buyer assumes Form 222 compliance; zero medical claims provided.
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.
Reviews
There are no reviews yet.